DUBAI: AstraZeneca is creating a separate division for vaccines and antibody therapies, the drugmaker said on Tuesday, to focus on its COVID-19 shot and the development of coronavirus treatments after a series of setbacks during the pandemic.
Reuters reported in July that the Anglo-Swedish company was exploring options for its vaccine business and expected to have greater clarity on the matter by the end of 2021.
The new division, which will be led by executive vice president of Europe and Canada, Iskra Reic, will combine research and development, manufacturing, commercial and medical teams, a company spokesperson said.
“The team will be dedicated to our COVID-19 vaccine, our long-acting antibody combination and our developmental vaccine addressing multiple variants of concern, as well as to our existing portfolio for respiratory viral disease,” the spokesperson said.
The decision to set up a new business comes after a tumultuous 18 months for the drugmaker, which developed its COVID-19 vaccine in conjunction with Oxford University.
Production problems forced the company to cut deliveries to the European Union this year, prompting the bloc to launch a legal challenge. Governments have also restricted its use among certain age groups due to links to rare blood clots and its application for US approval is taking longer than expected.
But positive results from trials of its antibody cocktail as a preventative shot against COVID-19 have given the company a major boost, potentially positioning it as a supplier of both COVID-19 vaccines and treatments.
The creation of the separate vaccines division was first reported by the Financial Times.
The move indicates AstraZeneca sees a future for its COVID-19 shot beyond the pandemic but shouldn’t be taken as a sign it is planning a full-scale entry into the broader vaccine market, Hargreaves Lansdown analyst Nicholas Hyett said.
“That would require significant new research and development investment, and as yet we have no indication that this is forthcoming,” he said.
AstraZeneca has pledged to supply vaccines at cost during the pandemic. The not-for-profit strategy and challenges with the shot fueled speculation about whether it would want to keep the business in the long term.
While AstraZeneca’s COVID-19 vaccine remained a drag on profits in the second quarter, sales of the shot more than tripled to $894 million from the first three months of the year, making it one of the company’s best-selling products.
AstraZeneca is due to report third-quarter results on Friday.
AstraZeneca to set up division for vaccines and antibody therapies
https://arab.news/gh72t
AstraZeneca to set up division for vaccines and antibody therapies
- The new division will combine research and development, manufacturing, commercial and medical teams
- The decision to set up a new business comes after a tumultuous 18 months for the drugmaker
Dense toxic fog shrouds Delhi as air quality hits severe levels
- Danish badminton star withdraws from India Open due to Delhi’s air pollution
- Air quality worst since the peak winter smog season in November last year
NEW DELHI: Residents of Delhi woke up to hazardous air quality on Sunday as a thick blanket of toxic smog and fog engulfed the Indian capital region, pushing air pollution into “severe” levels for the first time this year.
Home to 30 million people, Delhi has not recorded a single “clean air” day since September 2023, with Air Quality Index readings hitting high above the 50 score throughout the past two years.
On the AQI scale from 0 to 500, good air quality is represented by levels below 50, while levels above 300 are dangerous.
Based on Central Pollution Control Board data, the overall AQI was around 439–444, with several stations across Delhi reaching almost 500 — the worst since the peak winter smog season in early November.
The air quality is so bad that a Danish badminton star, Anders Antonsen, withdrew from the ongoing India Open, saying the city was not fit to host the tournament. Antonsen, who is the discipline’s No. 3, said in an Instagram story that the decision was due to “extreme pollution.”
While the athlete chose to pay a $5,000 fine rather than spend a few days in Delhi, its residents are left with little choice but to endure its toxic air.
“To protect myself, I use an N90 mask and drink lots of water. Still, in the first week of January, the smog impacted me with a bad throat and cold, hitting me badly. You are always exposed and risk your health,” said Akriti Chaudhary, a student activist in Delhi.
“The situation is worse for those people who live in the industrial area of Delhi and don’t have the luxury of green cover. They suffer a lot. Different parts of the population suffer differently, but the fact is that all suffer one way or another.”
For Dr. D. Raghunandan, a climate expert and member of a newly launched citizen initiative, SSANS, which acts as a pressure group to urge the government to act to improve air quality, the pollution has already become unavoidable.
“You just have to live with it. There is no way you can avoid it. Like 90 percent of Delhi’s population can’t escape it. Those who have a lot of money can stay indoors with air purifiers,” he said.
“We are concerned that not much is being done to contain the problem. What little is being done is cosmetic. You just have a few small water guns going around the city on tempos and spraying water.”
He compared Delhi’s problem to what China’s capital faced before.
“Look at the way the badminton event has panned out. Gradually, the pollution will start hitting. Ten years ago, Beijing was worse than Delhi in air pollution. And many large companies and corporations decided to leave Beijing,” Raghunandan told Arab News.
“Do you think those guys are going to stay in Delhi? If the pollution stays like this, they’ll move out.”
